Tag Archive for: Diabeloop DBLG2

ViCentra Scales Commercial Manufacturing, Triples Capacity and Strengthens Unit Economics

/in

Commercial-scale production of Kaleido consumables begins at contract manufacturer Phillips Medisize Manufacturing capacity more than triples, with initial capacity to support over 17,000 users Volume manufacturing drives gross margin expansion Utrecht, the Netherlands — May 28, 2026 ViCentra, a European medical device company commercializing the Kaleido insulin patch pump system, today announced that commercial‑scale production […]

Read more

ViCentra Announces Commercial Launch of New Smartphone-Controlled Kaleido Automated Insulin Delivery Patch Pump System

/in

New system combines Kaleido with Diabeloop’s DBLG2 algorithm and Dexcom G7, with first commercial deliveries in Germany and the Netherlands planned for later this summer Enables insulin automation to be controlled directly from the user’s smartphone, rather than a separate dedicated handset Starting on Kaleido today with Diabeloop’s DBLG1 algorithm is the fastest path to […]

Read more
© Optimum Strategic Communications.